Detlev Biniszkiewicz's most recent trade in ITeos Therapeutics Inc was a trade of 3,500 Common Stock done at an average price of $51.9 . Disclosure was reported to the exchange on Jan. 3, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ITeos Therapeutics Inc | Detlev Biniszkiewicz | Director | Sale of securities on an exchange or to another person at price $ 51.90 per share. | 03 Jan 2022 | 3,500 | 0 | - | 51.9 | 181,650 | Common Stock |
ITeos Therapeutics Inc | Detlev Biniszkiewicz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 3,500 | 13,108 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Detlev Biniszkiewicz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 03 Jan 2022 | 3,500 | 3,500 | - | 19 | 66,500 | Common Stock |
ITeos Therapeutics Inc | Detlev Biniszkiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 16,608 | 16,608 | - | - | Stock Option (Right to Buy) | |
ITeos Therapeutics Inc | Detlev Biniszkiewicz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 16,608 | 0 | - | - | Stock Option (Right to Buy) |